2013
2006 | 2007 | 2008 | 2009 (link to created pages)
January 2013
Palmetto Leans Toward Median Pricing for MDx Tests
Coverage Denied for Most MDx Tests
Court Rejects Bostwick’s Request to Dismiss Whistleblower Lawsuit
February 2013
Palmetto Slashes MDx Test Reimbursement
LipoSciences Raises $45 Million from IPO
Quest Diagnostics 2012 Financials
March 2013
Palmetto Likely to Revise MDx Test Pricing
Aurora Diagnostics Hires “Crisis Management” Expert
BioReference Buys Two Labs in Florida
April 2013
Growth Slows in Automatic Pathology
Aetna Slashes its Lab Fee Schedule
Proposed Budget Calls for Lab Fee Cuts
May 2013
Clock is Ticking for Labs to Submit Justification for Higher MDx Test Rates
Publicly-Traded Lab CEOs Paid Average of $3.3 Million
Quest Buys Advanced Toxicology Network
June 2013
Labs Jump to Offer BRCA1/2 Testing Following Supreme Court Ruling
Cap Presses Aetna for Explanation on New Rates
OIG Medicare Pays too Much for Lab Tests
July 2013
Medicare to Slash Technical Rates
Cms Seeking Rate Review for All Lab Tests
Quest Antitrust Case Dismissed
August 2013
CMS Move Toward “Packaged Payments” Means Lower Reimbursement for Lab Tests
Labcorp Shoots Down Takeover Rumors
Labs brace For CMS Decision on Molecular Tests
September 2013
CAP Asks CMS to Toss 2014 Payment Scheme
Riedel Dogs Quest and Labcorp With Medicaid Lawsuits
Lab Stocks up 3% YTD
October 2013
Final Medicare NLAs for Most MDx Tests Look Reasonable
Quest Offers New BRCA Test at 25% Discount
Foundation Medicine Raises $110 Million From IPO
November 2013
Florida Attorney General Joins Medicaid Pricing Lawsuit
PFS Final Rule Delayed Until Nov. 27; Cuts Expected for Some Key Codes
Sunset of EHR Safe Harbor Will Bring Big Change to Lab Marketplace
December 2013
Pathology Armageddon Avoided But IHC Rate Cut Will Sting
Where Will Savings to Avoid 20% PFS Cut Come From?
CMS Finalizes Plans to Revalue Lab Test Codes; CLFS For 2014 is -0.75%